Neurocrine Biosciences, Inc. (BIT:1NBIX)
Italy flag Italy · Delayed Price · Currency is EUR
114.50
-3.75 (-3.17%)
At close: Feb 11, 2026

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '13 Dec '12
INGREZZA Revenue
2.51B2.31B
INGREZZA Revenue Growth
8.65%26.01%
CRENESSITY Revenue
301.20M1.70M
CRENESSITY Revenue Growth
17617.65%-
ONGENTYS and Other Product Revenue
19.00M15.40M
ONGENTYS and Other Product Revenue Growth
23.38%-37.40%
Total Net Product Revenue
2.83B2.33B
Total Net Product Revenue Growth
21.59%25.26%
Royalties Revenue
-18.60M
Royalties Revenue Growth
--12.26%
Collaboration and Other Revenue
-6.10M
Collaboration and Other Revenue Growth
-15.09%
Total Collaboration Revenue
26.60M24.70M
Total Collaboration Revenue Growth
7.69%-6.79%
Revenue (Other)
-301.20M-1.70M
Revenue (Total)
2.86B2.36B
Revenue (Total) Growth
21.45%24.81%
Updated Dec 31, 2025. Data Source: Fiscal.ai.